Human Reproduction Update Advance Access published online on October 27, 2006
Human Reproduction Update, doi:10.1093/humupd/dml002
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Department of Obstetrics and Gynecology, University of British Columbia, Child and Family Research Institute, Vancouver, British Columbia, Canada
* To whom correspondence should be addressed. Ovarian cancer is the sixth most common cancer and the fifth leading cause of cancer-related death among women in developed countries. Greater than 85% of human ovarian cancer arises within the ovarian surface epithelium (OSE), with the remainder derived from granulosa cells or, rarely, stroma or germ cells. The pathophysiology of ovarian cancer is the least understood among all major human malignancies because of a poor understanding of the aetiological factors and mechanisms of ovarian cancer progression. There is increasing evidence suggesting that several key reproductive hormones, such as GnRH, gonadotrophins and sex steroids, regulate the growth of normal OSE and ovarian cancer cells. The objective of this review was to highlight the effects of these endocrine factors on ovarian cancer cell growth and to summarize the signalling mechanisms involved in normal human OSE and its neoplastic counterparts.
Received October 19, 2005
Revised January 17, 2006
Accepted January 23, 2006
Article
Endocrine signaling in ovarian surface epithelium and cancer
Peter C.K. Leung 1 * and Jung-Hye Choi 1
Peter C.K. Leung, E-mail: peleung{at}interchange.ubc.ca
![]()
Abstract ![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
P. M. Grimley, R. K. Matsuno, P. S. Rosenberg, D. E. Henson, A. M. Schwartz, and W. F. Anderson Qualitative Age Interactions between Low-grade and High-grade Serous Ovarian Carcinomas Cancer Epidemiol. Biomarkers Prev., August 1, 2009; 18(8): 2256 - 2261. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. N. Armaiz-Pena, L. S. Mangala, W. A. Spannuth, Y. G. Lin, N. B. Jennings, A. M. Nick, R. R. Langley, R. Schmandt, S. K. Lutgendorf, S. W. Cole, et al. Estrous Cycle Modulates Ovarian Carcinoma Growth Clin. Cancer Res., May 1, 2009; 15(9): 2971 - 2978. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. J. Murdoch, E. A. Van Kirk, and Youqing Shen Pathogenic Reactions of the Ovarian Surface Epithelium to Ovulation, Dimethylbenzanthracene, and Estrogen are Negated by Vitamin E Reproductive Sciences, October 1, 2008; 15(8): 839 - 845. [Abstract] [PDF] |
||||
![]() |
T.-V. Do, L. A. Kubba, M. Antenos, A. W. Rademaker, C. D. Sturgis, and T. K. Woodruff The Role of Activin A and Akt/GSK Signaling in Ovarian Tumor Biology Endocrinology, August 1, 2008; 149(8): 3809 - 3816. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-H. Choi, A. S. T. Wong, H.-F. Huang, and P. C. K. Leung Gonadotropins and Ovarian Cancer Endocr. Rev., June 1, 2007; 28(4): 440 - 461. [Abstract] [Full Text] [PDF] |
||||




